Publication | Closed Access
Phase I Trial of TGF-β2 Antisense GM-CSF Gene-Modified Autologous Tumor Cell (TAG) Vaccine
54
Citations
45
References
2011
Year
On the basis of safety and clinical and immunologic results, further evaluation of bifunctional vaccines is warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1